Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

davita inc. - DVA

DVA

Close Chg Chg %
149.25 -8.56 -5.73%

Closed Market

140.69

-8.56 (5.73%)

Volume: 2.26M

Last Updated:

Feb 6, 2026, 3:59 PM EDT

Trade Now

Company Overview: davita inc. - DVA

DVA Key Data

Open

$149.25

 Day Range

139.57 - 151.26

52 Week Range

101.00 - 178.38

 Market Cap

$10.03B

Shares Outstanding

70.60M

 Public Float

66.78M

Beta

0.99

 Rev. Per Employee

N/A

P/E Ratio

15.16

 EPS

$10.13

Yield

0.00%

 Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

1.39M

  

DVA Performance

1 Week
 
 28.80%
 
1 Month
 
 26.36%
 
3 Months
 
 13.86%
 
1 Year
 
 -18.87%
 
5 Years
 
 28.99%
 

DVA Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 11
Full Ratings ➔

About davita inc. - DVA

DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.

DVA At a Glance

DaVita, Inc.
2000 16th Street
Denver, Colorado 80202-7198
Phone 1-720-631-2100 Revenue 13.64B
Industry Medical/Nursing Services Net Income 746.80M
Sector Health Services 2025 Sales Growth 6.457%
Fiscal Year-end 12 / 2026 Employees N/A
View SEC Filings

DVA Valuation

P/E Current 15.165
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 11.546
Price to Sales Ratio 0.632
Price to Book Ratio N/A
Price to Cash Flow Ratio 4.57
Enterprise Value to EBITDA 8.262
Enterprise Value to Sales 1.651
Total Debt to Enterprise Value 0.572

DVA Efficiency

Revenue/Employee N/A
Income Per Employee N/A
Receivables Turnover 4.611
Total Asset Turnover 0.77

DVA Liquidity

Current Ratio 1.292
Quick Ratio 1.241
Cash Ratio 0.249

DVA Profitability

Gross Margin 27.005
Operating Margin 14.737
Pretax Margin 9.872
Net Margin 5.474
Return on Assets 4.072
Return on Equity N/A
Return on Total Capital 5.905
Return on Invested Capital 6.224

DVA Capital Structure

Total Debt to Total Equity N/A
Total Debt to Total Capital 105.327
Total Debt to Total Assets 73.651
Long-Term Debt to Equity N/A
Long-Term Debt to Total Capital 100.952
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Davita Inc. - DVA

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
11.61B 12.14B 12.82B 13.64B
Sales Growth
-0.08% +4.57% +5.56% +6.46%
Cost of Goods Sold (COGS) incl D&A
8.94B 9.07B 9.32B 9.96B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
732.60M 745.44M 723.86M 715.35M
Depreciation
- 721.13M 736.47M 716.40M
Amortization of Intangibles
- 11.47M 8.97M 7.46M
COGS Growth
+3.34% +1.38% +2.84% +6.83%
Gross Income
2.67B 3.07B 3.49B 3.68B
Gross Income Growth
-10.05% +15.27% +13.60% +5.47%
Gross Profit Margin
+22.98% +25.33% +27.26% +27.00%
2022 2023 2024 2025 5-year trend
SG&A Expense
1.36B 1.47B 1.54B 1.67B
Research & Development
- - - -
-
Other SG&A
1.36B 1.47B 1.54B 1.67B
SGA Growth
+13.37% +8.77% +4.37% +8.79%
Other Operating Expense
- - - -
-
Unusual Expense
(5.92M) 22.88M (89.65M) 14.18M
EBIT after Unusual Expense
1.32B 1.58B 2.04B 2.00B
Non Operating Income/Expense
(6.90M) (106.05M) (101.79M) (69.69M)
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
26.52M 27.86M 26.19M 33.00M
Interest Expense
345.29M 294.98M 412.29M 579.93M
Interest Expense Growth
+23.43% -14.57% +39.77% +40.66%
Gross Interest Expense
357.96M 304.16M 420.27M 579.93M
Interest Capitalized
- 12.68M 9.18M 7.98M
Pretax Income
966.28M 1.18B 1.53B 1.35B
Pretax Income Growth
-36.37% +21.82% +30.01% -11.99%
Pretax Margin
+8.32% +9.70% +11.94% +9.87%
Income Tax
198.09M 220.12M 279.66M 293.11M
Income Tax - Current - Domestic
- 257.52M 238.44M 305.91M
Income Tax - Current - Foreign
- 16.25M 21.01M 31.53M
Income Tax - Deferred - Domestic
- (78.69M) (39.87M) (50.57M)
Income Tax - Deferred - Foreign
- 3.00M 535.00K (7.22M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
26.52M 27.86M 26.19M 33.00M
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
768.19M 956.98M 1.25B 1.05B
Minority Interest Expense
221.24M 265.44M 314.39M 331.91M
Net Income
546.95M 691.53M 936.34M 721.80M
Net Income Growth
-44.10% +26.44% +35.40% -22.91%
Net Margin Growth
+4.71% +5.70% +7.31% +5.29%
Extraordinaries & Discontinued Operations
- - - 25.00M
-
Discontinued Operations
- - - 25.00M
-
Net Income After Extraordinaries
546.95M 691.53M 936.34M 746.80M
Preferred Dividends
- - - -
-
Net Income Available to Common
546.95M 691.53M 936.34M 746.80M
EPS (Basic)
5.8817 7.6169 11.017 10.0611
EPS (Basic) Growth
-36.74% +29.50% +44.64% -8.68%
Basic Shares Outstanding
92.99M 90.79M 84.99M 74.23M
EPS (Diluted)
5.7072 7.4213 10.7288 9.84
EPS (Diluted) Growth
-35.87% +30.03% +44.57% -8.28%
Diluted Shares Outstanding
95.83M 93.18M 87.27M 75.89M
EBITDA
2.05B 2.35B 2.68B 2.73B
EBITDA Growth
-16.56% +14.73% +14.16% +1.76%
EBITDA Margin
+17.62% +19.33% +20.90% +19.98%

Snapshot

Average Recommendation HOLD Average Target Price 146.00
Number of Ratings 11 Current Quarters Estimate 2.336
FY Report Date 03 / 2026 Current Year's Estimate 13.922
Last Quarter’s Earnings 3.40 Median PE on CY Estimate N/A
Year Ago Earnings 10.78 Next Fiscal Year Estimate 16.087
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 5 5 7 7
Mean Estimate 2.34 3.67 13.92 16.09
High Estimates 2.46 4.03 14.36 17.16
Low Estimate 2.22 3.43 12.36 14.08
Coefficient of Variance 3.75 6.97 5.08 6.65

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 1 1 1
OVERWEIGHT 0 1 1
HOLD 8 8 9
UNDERWEIGHT 2 1 1
SELL 0 0 0
MEAN Hold Hold Hold

Insider Actions for Davita Inc. - DVA

Date Name Shares Transaction Value
Mar 21, 2025 Kathleen Alyce Waters Chief Legal & Pub. Affairs Off 97,754 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $143.45 per share 14,022,811.30
Mar 21, 2025 Javier J. Rodriguez Chief Executive Officer; Director 894,080 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 Javier J. Rodriguez Chief Executive Officer; Director 52,106 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 Kathleen Alyce Waters Chief Legal & Pub. Affairs Off 102,333 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $143.45 per share 14,679,668.85
Mar 21, 2025 Kathleen Alyce Waters Chief Legal & Pub. Affairs Off 99,648 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $143.45 per share 14,294,505.60
Mar 21, 2025 Dennis W. Pullin Director 961 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 Christopher M. Berry Chief Accounting Officer 15,991 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 Kathleen Alyce Waters Chief Legal & Pub. Affairs Off 105,092 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 Kathleen Alyce Waters Chief Legal & Pub. Affairs Off 98,693 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $143.45 per share 14,157,510.85
Mar 21, 2025 Kathleen Alyce Waters Chief Legal & Pub. Affairs Off 9,263 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 David P. Maughan Chief Operating Officer, DKC 14,474 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 Barbara Jean Desoer Director 349 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 Pamela M. Arway Director 25,235 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 Charles G. Berg Director 19,634 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 Joel Ackerman CFO and Treasuer 16,597 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 Joel Ackerman CFO and Treasuer 141,640 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $143.45 per share 20,318,258.00
Mar 21, 2025 Joel Ackerman CFO and Treasuer 144,971 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $143.45 per share 20,796,089.95
Mar 21, 2025 Joel Ackerman CFO and Treasuer 148,064 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 Adam H. Schechter Director 3,982 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 Wendy Lee Schoppert Director 349 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Davita Inc. in the News